Banu has a masters degree in Diagnostic Microbiology from Istanbul University, Cerrahpasa Medical School in Istanbul. She has previously worked at Oxford University at the John Radcliffe Hospital in Microbiology Department as a Specialist Biomedical Scientist. During her career, she discovered a growing interest in quality control practices within the hospital. Eventually, she left the clinical hospital for the private sector where she worked as QC Laboratory Supervisor. She hopes that her experience gained throughout her career will benefit the Scientific and Management team here at Neuro-Bio.
Dr Henry Tu
Henry graduated in Biomedical and Pharmaceutical from the University of Reading. His research focuses on the neurodegenerative mechanism of Alzheimer’s disease (AD); this led him to joining Neuro-Bio Ltd as a Postdoctoral researcher, exploring novel approaches to neurodegeneration. In his new role as Principal Scientist, his main responsibilities include the development of an AD diagnosis and prognosis assay, sourcing biospecimen samples from biobanks around the world and line managing research scientists.
Dr Giovanni Ferrati
Giovanni has a master in Neurobiology from the University of Turin in Italy, this was awarded with academic distinction. Additionally, he also has a bachelor in biotechnology from the university of Florence in Italy.
Dr Emily Pinkstone
Emily has a Master’s in Neuroscience and a PhD in Molecular and Cellular Neuro-Oncology. During this time, she developed a keen interest and love of neuroscientific research, which prompted her to join Neuro-bio as a Neuroscientist.
Sally has a Masters of Research in Neuropharmacology from Nottingham Trent. It was here where she discovered her love for cell signalling and neurodegenerative disease. Since then, Sally has been working on therapeutic applications for disease In Vitro. She has joined Neuro-bio as a Research Scientist with a primary focus on cell culture as part of the Drug Discovery team.
Matthew has an MBio in Biochemistry from the University of Warwick. After completing a year in industry with the company as an intern, he was given the opportunity to stay on at Neuro-Bio as a Research Scientist. Currently, his work is targeted towards the development of immunoassays which are used to detect a novel biomarker of Alzheimer’s disease.
Owen has an MSc in Molecular Neuroscience from the University of Bristol and a BSc in Biological Sciences from the University of Birmingham. He is currently working as part of the biomarker development team.